Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
editorial
. 1993 Oct;83(10):1379–1382. doi: 10.2105/ajph.83.10.1379

HIV prevention: an update on the status of methods women can use.

Z Stein
PMCID: PMC1694866  PMID: 8214223

Full text

PDF
1379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander N. J. Sexual transmission of human immunodeficiency virus: virus entry into the male and female genital tract. World Health Organization, Global Programme on Acquired Immune Deficiency Syndrome. Fertil Steril. 1990 Jul;54(1):1–18. doi: 10.1016/s0015-0282(16)53628-0. [DOI] [PubMed] [Google Scholar]
  2. Cameron D. W., Simonsen J. N., D'Costa L. J., Ronald A. R., Maitha G. M., Gakinya M. N., Cheang M., Ndinya-Achola J. O., Piot P., Brunham R. C. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 1989 Aug 19;2(8660):403–407. doi: 10.1016/s0140-6736(89)90589-8. [DOI] [PubMed] [Google Scholar]
  3. Cates W., Jr, Stone K. M. Family planning, sexually transmitted diseases and contraceptive choice: a literature update--Part I. Fam Plann Perspect. 1992 Mar-Apr;24(2):75–84. [PubMed] [Google Scholar]
  4. Clemetson D. B., Moss G. B., Willerford D. M., Hensel M., Emonyi W., Holmes K. K., Plummer F., Ndinya-Achola J., Roberts P. L., Hillier S. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA. 1993 Jun 9;269(22):2860–2864. [PubMed] [Google Scholar]
  5. Goldacre M. J., Loudon N., Watt B., Grant G., Loudon J. D., McPherson K., Vessey M. P. Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. Br Med J. 1978 Mar 25;1(6115):748–750. doi: 10.1136/bmj.1.6115.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kreiss J., Ngugi E., Holmes K., Ndinya-Achola J., Waiyaki P., Roberts P. L., Ruminjo I., Sajabi R., Kimata J., Fleming T. R. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA. 1992 Jul 22;268(4):477–482. [PubMed] [Google Scholar]
  7. Laga M., Manoka A., Kivuvu M., Malele B., Tuliza M., Nzila N., Goeman J., Behets F., Batter V., Alary M. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993 Jan;7(1):95–102. doi: 10.1097/00002030-199301000-00015. [DOI] [PubMed] [Google Scholar]
  8. Louv W. C., Austin H., Alexander W. J., Stagno S., Cheeks J. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis. 1988 Sep;158(3):518–523. doi: 10.1093/infdis/158.3.518. [DOI] [PubMed] [Google Scholar]
  9. Mertens T. E., Hayes R. J., Smith P. G. Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS. 1990 Jan;4(1):57–65. doi: 10.1097/00002030-199001000-00008. [DOI] [PubMed] [Google Scholar]
  10. Moscicki A. B., Winkler B., Irwin C. E., Jr, Schachter J. Differences in biologic maturation, sexual behavior, and sexually transmitted disease between adolescents with and without cervical intraepithelial neoplasia. J Pediatr. 1989 Sep;115(3):487–493. doi: 10.1016/s0022-3476(89)80863-7. [DOI] [PubMed] [Google Scholar]
  11. Niruthisard S., Roddy R. E., Chutivongse S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet. 1992 Jun 6;339(8806):1371–1375. doi: 10.1016/0140-6736(92)91195-e. [DOI] [PubMed] [Google Scholar]
  12. Plummer F. A., Simonsen J. N., Cameron D. W., Ndinya-Achola J. O., Kreiss J. K., Gakinya M. N., Waiyaki P., Cheang M., Piot P., Ronald A. R. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis. 1991 Feb;163(2):233–239. doi: 10.1093/infdis/163.2.233. [DOI] [PubMed] [Google Scholar]
  13. Rosenberg M. J., Davidson A. J., Chen J. H., Judson F. N., Douglas J. M. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health. 1992 May;82(5):669–674. doi: 10.2105/ajph.82.5.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rosenberg M. J., Gollub E. L. Commentary: methods women can use that may prevent sexually transmitted disease, including HIV. Am J Public Health. 1992 Nov;82(11):1473–1478. doi: 10.2105/ajph.82.11.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Saracco A., Musicco M., Nicolosi A., Angarano G., Arici C., Gavazzeni G., Costigliola P., Gafa S., Gervasoni C., Luzzati R. Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J Acquir Immune Defic Syndr. 1993 May;6(5):497–502. [PubMed] [Google Scholar]
  16. Stein Z. A. HIV prevention: the need for methods women can use. Am J Public Health. 1990 Apr;80(4):460–462. doi: 10.2105/ajph.80.4.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wasserheit J. N. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992 Mar-Apr;19(2):61–77. [PubMed] [Google Scholar]
  18. Zekeng L., Feldblum P. J., Oliver R. M., Kaptue L. Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS. 1993 May;7(5):725–731. doi: 10.1097/00002030-199305000-00018. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES